Publication | Closed Access

Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial

ObesityMetabolic SyndromeHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseLiver PhysiologyPharmacologyHepatotoxicityPharmacotherapyVersus PlaceboLiver DiseaseFatty Liver DiseasePhase 2MedicineDose-finding TrialHealth Sciences